BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ning P, Luo A, Mu X, Xu Y, Li T. Exploring the dual character of metformin in Alzheimer's disease. Neuropharmacology 2022;:108966. [PMID: 35077762 DOI: 10.1016/j.neuropharm.2022.108966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Woodfield A, Gonzales T, Helmerhorst E, Laws S, Newsholme P, Porter T, Verdile G. Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease. Int J Mol Sci 2022;23. [PMID: 36555450 DOI: 10.3390/ijms232415811] [Reference Citation Analysis]
2 Cao G, Gong T, Du Y, Wang Y, Ge T, Liu J. Mechanism of metformin regulation in central nervous system: Progression and future perspectives. Biomedicine & Pharmacotherapy 2022;156:113686. [DOI: 10.1016/j.biopha.2022.113686] [Reference Citation Analysis]
3 Li Z, Li S, Xiao Y, Zhong T, Yu X, Wang L. Nutritional intervention for diabetes mellitus with Alzheimer's disease. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1046726] [Reference Citation Analysis]
4 Galizzi G, Di Carlo M. Insulin and Its Key Role for Mitochondrial Function/Dysfunction and Quality Control: A Shared Link between Dysmetabolism and Neurodegeneration. Biology (Basel) 2022;11:943. [PMID: 35741464 DOI: 10.3390/biology11060943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]